NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

CompletedNA

Sponsor: University of California, Davis

Conditions: Influenza, Human

Interventions: Procalcitonin, Pharmacist-Led Education

Countries: United States

This will be a prospective, patient-oriented, pilot randomized clinical trial to evaluate (in aggregate) both the use of the Roche Cobas Liat Flu/RSV Assay and the use of pharmacist-led education for providers in the interpretation of these test results.

Eligibility overview

Sex: ALL

Age: — to 49 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients \<50 years of age who are evaluated in the emergency department for:
* suspected influenza, including symptoms of influenza-like illness (ILI - including fever \> 38 degrees Celsius and cough or sore throat), or
* non-specific upper respiratory infection (URI) for whom the clinician suspects the presence of RSV, or influenza, or lower respiratory infection LRI).
* Patients whose treating provider has ordered a Roche Cobas Liat Flu/RSV test.

Exclusion Criteria:

* Patients who are pregnant
* Prisoners
* Patients who are unable to give informed consent in English or Spanish.
* Provider is unwilling to wait for procalcitonin results.

Locations (1)

Sacramento, California, United States